Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemolizumab in Chronic Hepatic Pruritus
NCT07843420Phase 2Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 2 trial of nemolizumab in Pruritus Associated With Liver Disease, sponsored by Mayo Clinic. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
nemolizumab
03
Conditions
Pruritus Associated With Liver Disease
Beyond the preview
Go deeper on NCT07843420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843420.